Maggie Wilcox

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley et al. · Cell · 2017 · 1.3K citations · Full text

Life Sciences, Genetics, Oncology +16

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Charlotte E. Coles, Clare Griffin, Anna M. Kirby et al. · The Lancet · 2017 · 612 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

Frederick Arce Vargas, Andrew J.S. Furness, Kevin Litchfield et al. · Cancer Cell · 2018 · 585 citations · Full text

Medicine, Immunology, Oncology +17

Addressing overtreatment of screen detected DCIS; the LORIS trial

Adele Francis, Jeremy Thomas, Lesley Fallowfield et al. · European Journal of Cancer · 2015 · 375 citations · Full text

Medicine, Internal Medicine, Preventive Medicine +5

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Ian Smith, J.F.R. Robertson, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 317 citations · Full text

Medicine, Oncology, Pharmacology +17